Correlation Between Tff Pharmaceuticals and Orgenesis

Can any of the company-specific risk be diversified away by investing in both Tff Pharmaceuticals and Orgenesis at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tff Pharmaceuticals and Orgenesis into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Tff Pharmaceuticals and Orgenesis, you can compare the effects of market volatilities on Tff Pharmaceuticals and Orgenesis and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tff Pharmaceuticals with a short position of Orgenesis. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tff Pharmaceuticals and Orgenesis.

Diversification Opportunities for Tff Pharmaceuticals and Orgenesis

0.87

Correlation Coefficient

Tff Pharmaceuticals  Orgenesis

Very poor diversification

The 3 months correlation between Tff and Orgenesis is 0.87. Overlapping area represents the amount of risk that can be diversified away by holding Tff Pharmaceuticals and Orgenesis in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Orgenesis and Tff Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tff Pharmaceuticals are associated (or correlated) with Orgenesis. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Orgenesis has no effect on the direction of Tff Pharmaceuticals i.e., Tff Pharmaceuticals and Orgenesis go up and down completely randomly.

Pair Corralation between Tff Pharmaceuticals and Orgenesis

Given the investment horizon of 90 days Tff Pharmaceuticals is expected to under-perform the Orgenesis. But the stock apears to be less risky and, when comparing its historical volatility, Tff Pharmaceuticals is 1.04 times less risky than Orgenesis. The stock trades about -0.09 of its potential returns per unit of risk. The Orgenesis is currently generating about -0.03 of returns per unit of risk over similar time horizon. If you would invest  1,960  in Orgenesis on September 23, 2024 and sell it today you would lose (1,838) from holding Orgenesis or give up 93.78% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Strong
Accuracy	91.55%
Values	Daily Returns

Tff Pharmaceuticals  vs.  Orgenesis

Tff Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Tff Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Even with unsteady performance in the last few months, the Stock's technical and fundamental indicators remain relatively invariable which may send shares a bit higher in January 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

Orgenesis

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Orgenesis has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's technical and fundamental indicators remain comparatively stable which may send shares a bit higher in January 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Pair Trading with Tff Pharmaceuticals and Orgenesis

The main advantage of trading using opposite Tff Pharmaceuticals and Orgenesis positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tff Pharmaceuticals position performs unexpectedly, Orgenesis can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Orgenesis will offset losses from the drop in Orgenesis' long position.

The idea behind Tff Pharmaceuticals and Orgenesis pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.